Workshop Overview
Cervical cancer is a major women's health concern, but it is also one of the cancers for which effective prevention and early detection strategies are available. Human papillomavirus (HPV) infection is the principal cause of cervical cancer, making HPV vaccination, appropriate screening and timely follow-up essential components of cervical cancer control.
BioGenesis Health Cluster proposes to organise a specialised Cervical Cancer Prevention, Screening and Clinical Demonstration Workshop as part of the 8th Global Cancer Summit 2027 in Aizawl, Mizoram.
Led by an experienced gynaecologist, gynaecological oncologist, clinician or cancer scientist, the workshop will combine expert lectures, anatomical demonstrations, scientific presentations and interactive discussions.
The programme will bring together clinicians, oncologists, surgeons, researchers, medical students, healthcare workers, NGOs and members of the general public to improve understanding of cervical cancer risk factors, HPV vaccination, screening methods, diagnostic procedures and treatment options.
With particular attention to women's health and the healthcare needs of Northeast India, the workshop aims to promote preventive healthcare, encourage participation in appropriate screening programmes and strengthen collaboration between healthcare institutions, research organisations and community groups.
Scientific programme and demonstrations
Session 1 — Understanding Cervical Cancer
Introduction to cervical anatomy, HPV infection, precancerous cervical changes, risk factors, warning signs and the development of cervical cancer.
Session 2 — Clinical Demonstration and Cervical Health
Demonstration using an anatomical model to explain cervical anatomy, speculum examination principles, the collection of cervical screening samples and the role of colposcopy in further evaluation.
Session 3 — Screening and Early Detection
Explain HPV testing, cervical cytology (Pap testing), visual inspection with acetic acid where appropriate, and follow-up of abnormal results according to applicable guidelines.
Session 4 — HPV Vaccination and Prevention
Discuss the relationship between HPV and cervical cancer, vaccination benefits, appropriate vaccination schedules, myths and misconceptions, and the importance of continued screening when recommended.
Session 5 — Diagnosis, Treatment and Scientific Advances
An overview of biopsy and pathology, staging, treatment pathways, surgery, radiotherapy, systemic treatments and emerging research in cervical cancer.
Session 6 — Community Awareness and Expert Interaction
Open discussion on HPV vaccination, screening access, common misconceptions, overcoming stigma and improving access to women's health services.
Intended participants
- Clinicians, gynaecologists and oncologists
- Screening guidelines, clinical assessment, referral pathways and evidence-based management.
- Scientists and research scholars
- HPV biology, cervical carcinogenesis, diagnostic technologies and research collaboration.
- Medical students and healthcare workers
- Preventive healthcare, screening education, patient communication and referral awareness.
- Women, NGOs and the general public
- HPV vaccination awareness, screening, prevention and access to appropriate health services.
Expected learning outcomes
- Better understanding of HPV infection and its role in cervical cancer.
- Increased awareness of HPV vaccination and cervical cancer prevention.
- Improved knowledge of screening methods and appropriate follow-up.
- Familiarity with clinical examination and diagnostic procedures through model-based demonstrations.
- Greater understanding of diagnostic and treatment pathways.
- Stronger collaboration between clinicians, research institutions, NGOs and community health organisations.
- Practical recommendations for improving women's cancer awareness in Northeast India.
Suggested workshop arrangements
| Component |
Recommended format |
| Duration |
2-3 hours |
| Lead faculty |
Experienced gynaecologist, gynaecological oncologist or cancer scientist |
| Demonstration |
Anatomical model, screening diagrams and illustrative clinical cases |
| Scientific discussion |
Clinicians, pathologists, researchers and oncology specialists |
| Public interaction |
Question-and-answer session and awareness education |
| Learning material |
Illustrated handouts on HPV, vaccination, screening and referral services |
Demonstrations should use anatomical models and approved educational materials. Any patient-based clinical demonstration requires informed consent, privacy protection and appropriate institutional arrangements.